Zobrazeno 1 - 10
of 193
pro vyhledávání: '"C, Caranobe"'
Publikováno v:
Annales Françaises d'Anesthésie et de Réanimation. 28:892-896
We relate three cases of IgM gammopathy with haemostatic dysfunction in the perioperative period. The acquired von Willebrand syndrome due to IgM gammopathy is rare and sometimes serious. Its different treatments and their efficiency are discussed: d
Publikováno v:
Scandinavian Journal of Haematology. 25:214-220
Certain platelet functions were evaluated in 24 patients with secondary polycythaemia (SP) and in a large number of patients suffering from myeloproliferative disorders (MD'S): 89 patients with chronic myeloid leukaemia (CML) at different stages of d
Publikováno v:
Scandinavian Journal of Haematology. 25:289-295
Platelet serotonin (5-HT) uptake and storage in the presence and absence of reserpine were studied simultaneously with platelet volume, density and dense bodies content (mepacrine test) in 33 patients affected with myeloproliferative disorders (MD):
Publikováno v:
Scandinavian Journal of Haematology. 26:123-129
Membrane glycoproteins (GP) are implicated in platelet functions. In myeloproliferative diseases (MD), some of these functions are known to be perturbed. 16 patients with various MD were investigated for platelet functions (retention to glass beads,
Autor:
S Saivin, A.M. Gabaig, Pierre Sie, Jean-Claude Lormeau, G Houin, Bernard Boneu, C. Caranobe, V. Peyrou, B. Crepon
Publikováno v:
Scopus-Elsevier
SummaryThis study compares some in vivo pharmacological properties of CY 216 and of its ACLM and BCLM components having a molecular weight above and below 5.4 kDa respectively. The anti-factor Xa/anti-thrombin ratio of these compounds determined in a
Publikováno v:
Scopus-Elsevier
The relationship between the antithrombotic activity of dermatan sulfate (DS) in vivo and its catalytic effect on the inhibition of thrombin by heparin cofactor II (HC II) in vitro was investigated. DS was depolymerized by Smith degradation and the f
Publikováno v:
British Journal of Haematology. 83:622-626
Summary. This study compares the ability of unfractionated heparin (UH) and of three low molecular weight heparins (LMWHs) to inhibit venous thrombosis growth in the rabbit. Logiparin® (LHN-1), Fraxiparin® (CY216) and CY222 were selected because th
Autor:
F. Dol, C. Caranobe, Maurice Petitou, Pierre Sie, Sylvie Saivin, Georges Houin, Bernard Boneu, J.C. Lormeau
Publikováno v:
Thrombosis Research. 66:527-535
In order to improve the pharmacokinetic properties of unfractionated dermatan sulfate (UDS, mean MW:25kD), the disposition of 4 low molecular weight dermatan sulfates (LMWDS) with a mean MW ranging from 15 to 4 kD was investigated in the rabbit. In c
Autor:
B. Crepon, M. Level, Pierre Sie, Jean-Claude Lormeau, Bernard Boneu, M. Petitou, Georges Houin, C. Caranobe, Sylvie Saivin
Publikováno v:
British Journal of Haematology. 80:509-513
Summary This paper compares the pharmacological properties of a new succinyl dermatan sulphate derivative (Suc-DS) to those of the natural dermatan sulphate (DS). Suc-DS was on average 2–3 times more potent than DS in catalysing the inhibition of t
Publikováno v:
Thrombosis and Haemostasis. 67:550-555
SummaryThis paper reports on the pharmacodynamic properties of butyryl derivatives of unfractionated heparin (C4-UH) and of low molecular weight heparin (C4-CY 216) after bolus intravenous injection, constant infusion and subcutaneous administration